Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Companyâs Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Companyâs Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļALC
āļāļ·āđāļāļāļĢāļīāļĐāļąāļAlcon AG
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 09, 2019
āļāļĩāļāļĩāđāļMr. David J. Endicott
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ25599
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļApr 09
āļāļĩāđāļāļĒāļđāđRue Louis d'Affry 6
āđāļĄāļ·āļāļFRIBOURG
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđSIX Swiss Exchange
āļāļĢāļ°āđāļāļĻSwitzerland
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ1700
āđāļāļĢāļĻāļąāļāļāđ41589113800
āđāļ§āđāļāđāļāļāđhttps://www.alcon.ch/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļALC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 09, 2019
āļāļĩāļāļĩāđāļMr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
Mr. Ian Bell
Chief Operating Officer
Ms. Karen J. May, CPA
Independent Director
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Mr. Scott Harlan Maw
Independent Director
Ms. Ines Poeschel
Independent Director
Ms. Lynn Dorsey Bleil
Independent Director
Mr. Leon Sergio Duplan Fraustro
Mr. Leon Sergio Duplan Fraustro
Senior Vice President, President - Americas
Senior Vice President, President - Americas
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
Mr. Ian Bell
Chief Operating Officer
Ms. Karen J. May, CPA
Independent Director
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Franklin FTSE Switzerland ETF
Global X Aging Population ETF
iShares MSCI Switzerland ETF
First Trust Indxx Medical Devices ETF
Running Oak Efficient Growth ETF
BNY Mellon Dynamic Value ETF
Global X S&P Catholic Values Developed ex-US ETF
BNY Mellon Women's Opportunities ETF
Fidelity Fundamental Developed International ETF
First Trust Switzerland Alphadex Fund
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Franklin FTSE Switzerland ETF
āļŠāļąāļāļŠāđāļ§āļ2.87%
Global X Aging Population ETF
āļŠāļąāļāļŠāđāļ§āļ2.81%
iShares MSCI Switzerland ETF
āļŠāļąāļāļŠāđāļ§āļ2.36%
First Trust Indxx Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ1.72%
Running Oak Efficient Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.67%
BNY Mellon Dynamic Value ETF
āļŠāļąāļāļŠāđāļ§āļ1.55%
Global X S&P Catholic Values Developed ex-US ETF
āļŠāļąāļāļŠāđāļ§āļ1.2%
BNY Mellon Women's Opportunities ETF
āļŠāļąāļāļŠāđāļ§āļ0.91%
Fidelity Fundamental Developed International ETF
āļŠāļąāļāļŠāđāļ§āļ0.84%
First Trust Switzerland Alphadex Fund
āļŠāļąāļāļŠāđāļ§āļ0.78%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
400.00M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021